(-0.08%) 5 464.93 points
(-0.41%) 38 953 points
(0.26%) 17 764 points
(0.24%) $81.02
(-3.23%) $2.67
(-0.92%) $2 309.40
(-0.39%) $28.76
(1.51%) $1 001.30
(0.31%) $0.936
(0.79%) $10.69
(0.36%) $0.791
(-0.13%) $87.38
Live Chart Being Loaded With Signals
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases...
Stats | |
---|---|
本日の出来高 | 764 531 |
平均出来高 | 1.32M |
時価総額 | 0.00 |
EPS | $0.260 ( Q1 | 2022-11-21 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.270 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0280 (7.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-11-30 | Robinson James A. Jr. | Sell | 25 000 | Stock Option (Right to Buy) |
2022-11-30 | Vanlent Anne | Sell | 14 000 | Stock Option (Right to Buy) |
2022-11-30 | Rosen James | Sell | 1 000 | Common Stock |
2022-11-30 | Rosen James | Sell | 14 000 | Stock Option (Right to Buy) |
2022-11-30 | Aliski William | Sell | 8 500 | Common Stock |
INSIDER POWER |
---|
-30.81 |
Last 91 transactions |
Buy: 4 369 607 | Sell: 1 870 885 |
ボリューム 相関
Applied Genetic 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Applied Genetic 相関 - 通貨/商品
Applied Genetic 財務諸表
Annual | 2022 |
収益: | $325 000 |
総利益: | $325 000 (100.00 %) |
EPS: | $-1.590 |
FY | 2022 |
収益: | $325 000 |
総利益: | $325 000 (100.00 %) |
EPS: | $-1.590 |
FY | 2021 |
収益: | $500 000 |
総利益: | $0.00 (0.00 %) |
EPS: | $-1.770 |
FY | 2020 |
収益: | $2.45M |
総利益: | $0.00 (0.00 %) |
EPS: | $-2.17 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Applied Genetic
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, Inc.; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。